# FDA Inspection 1201180 - Gregory B. Hammer,  M.D. - March 15, 2023

Source: https://www.keypedia.com/records/fda_inspections/gregory-b-hammer-md/6551748a-a708-421e-a5aa-32a554093095
Source feed: FDA_Inspections

> FDA Inspection 1201180 for Gregory B. Hammer,  M.D. on March 15, 2023. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1201180
- Company Name: Gregory B. Hammer,  M.D.
- Inspection Date: 2023-03-15
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1140073 - 2021-03-29](https://www.keypedia.com/records/fda_inspections/gregory-b-hammer-md/88cd27be-0c79-4d3a-82bf-e9024abf40e6)
- [FDA Inspection 923995 - 2015-04-17](https://www.keypedia.com/records/fda_inspections/gregory-b-hammer-md/681069a6-99d7-497b-b654-85526aabfb8d)
- [FDA Inspection 828782 - 2013-04-12](https://www.keypedia.com/records/fda_inspections/gregory-b-hammer-md/3358a054-be51-46cb-9ac6-d8a0ab8b1b0c)

Company: https://www.keypedia.com/companies/gregory-b-hammer-md/41ba71a5-09a3-42e7-a411-8acf16b725ca

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c